4//SEC Filing
Bizily Scott 4
Accession 0000950170-25-036696
CIK 0001650648other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 8:00 PM ET
Size
5.7 KB
Accession
0000950170-25-036696
Insider Transaction Report
Form 4
Bizily Scott
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-06+78,500→ 78,500 totalExercise: $4.14Exp: 2035-03-05→ Common Stock (78,500 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001920738
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 8:00 PM ET
- Size
- 5.7 KB